retatrutide phase 2 obesity trial results New 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Eli Lilly infiltrates anti-obesity market

The melanoma question has been addressed across multiple post-marketing surveillance reports for SCENESSE (the approved product)

adults have taken a GLP-1 drug

Zrenner R, Stitt M, Sonnewald U, Boldt R

GLP-1s are becoming much more than a pharmaceutical trend

The Switching Protocol If switching from semaglutide to tirzepatide: Take your last dose of semaglutide as scheduled Wait one week (your normal injection day) Start tirzepatide at the initial dose recommended by your provider Follow the prescribed titration schedule Start tirzepatide at the dose recommended by your provider, even if you were on a higher dose of semaglutide